Patent ID: 8962688
Filing Date: 2015-02-24
Classification: A61K,A61P

Abstract:
1. A method for treating a gastrointestinal disorder in a mammalian subject, which comprises administering to the subject in need thereof, a combination of (a) a pharmaceutically effective amount of a prostaglandin (PG) compound of 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E (b) a pharmaceutically effective amount of a H wherein the gastrointestinal disorder is selected from the group consisting of gastric ulcer, bleeding ulcer, duodenal ulcer, NSAID-induced ulcer, peptic ulcer, erosive esophagitis, gastroesophageal reflux, wherein the dose of said prostaglandin compound is 1-100 μg and the dose of said H